LANSING, Mich., May 6, 2013 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today the development of a new genomic test that offers the beef cattle industry an unprecedented level of information on the genetic potential of individual animals.
Neogen's new GeneSeek® Genomic Profiler™ (GGP-HD) contributes comprehensive data included in Angus genomic-enhanced expected progeny differences (GE-EPDs), which reveal an animal's genetic potential well before breeding, as well as the animal's parentage, and important genetic trait and disease information on the animal. With Angus Genetics Inc. (AGI), Neogen recently announced the availability of a breed-specific version of the new product, the GeneSeek Angus GGP-HD.
"This new test solidifies Neogen's position as the leading provider of genetic testing to the cattle industry," said James Herbert, Neogen's CEO and chairman. "Especially now with the recent changes in the cattle industry, decisions ranchers make on individual animals can be critical to maximizing that ranch's profitability. With this one test, a rancher can decide if the heifer has the genetic merit to keep on the ranch, and exclude the animals that would make poor choices for breeding, or would develop a genetic condition that would reduce its value."
Results from the advanced GeneSeek Angus GGP-HD test will be incorporated into Angus GE-EPDs, which are available on a weekly basis through the American Angus Association National Cattle Evaluation. In 2009, AGI, in collaboration with Neogen's Igenity subsidiary, provided the beef industry with Angus-specific GE-EPDs. Since that time, AGI has continued to foster the research and implementation strategy with GeneSeek to continue to bring high-quality genomic tests into the weekly EPD updates used by Angus breeders and their customers.The GeneSeek GGP-HD technology is an improvement on the well-known Igenity Profile for Angus test. The custom, high density chip features a unique new design that features nearly 78,000 single nucleotide polymorphisms (SNPs) selectively chosen from studies on thousands of animals. The test provides parentage information at no extra charge. Specialty add-on tests will be available for a number of genetic conditions at minimal additional cost.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts